SIIL Jaibhim Wind Farm - Onshore Wind Energy Facility in India

SIIL Jaibhim Wind Farm is an operational onshore wind energy facility located in India, owned by Serum Institute of India Limited. With a capacity of 33.6 MW, it falls within the medium-scale range for wind farms in the country, contributing to India's growing renewable energy portfolio. The facility operates under India's national renewable energy framework, which includes targets under the National Solar Mission and state-level Renewable Purchase Obligations (RPOs). Onshore wind technology is well-established in India, particularly in states like Tamil Nadu, Gujarat, and Maharashtra, where wind regimes are favorable. The 33.6 MW capacity indicates a moderate-sized installation typical of corporate-backed wind projects. This wind farm supports India's goal of achieving 500 GW of non-fossil fuel capacity by 2030. By generating clean electricity, it helps reduce greenhouse gas emissions and dependence on fossil fuels. The project also aligns with the corporate sustainability objectives of Serum Institute of India Limited, a major pharmaceutical company.

The wind farm is located in a region with moderate wind speeds suitable for energy generation. Onshore wind projects can have visual impacts on the landscape and may affect local bird and bat populations. However, proper siting and mitigation measures can minimize these effects. The facility contributes to reducing air pollution and carbon emissions compared to conventional power plants.